Development of Anti-idiotypic Monoclonal Antibody Mimicking SARS-CoV-2 Receptor Binding Domain
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Development of Anti-idiotypic Monoclonal Antibody Mimicking SARS-CoV-2 Receptor Binding Domain ; day:25 ; month:4 ; year:2024 ; pages:1-9
Molecular biotechnology ; (25.4.2024), 1-9
- Urheber
-
Kılıç, Gamze
Demirkan, Elif
Yücel, Fatıma
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12033-024-01138-1
- URN
-
urn:nbn:de:101:1-2407120652268.835024467508
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kılıç, Gamze
- Demirkan, Elif
- Yücel, Fatıma
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
Monoclonal antibody therapy
In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
Casirivimab-imdevimab monoclonal antibody treatment for an immunocompromised patient with persistent SARS-CoV-2 infection: a case report
Quantitative measurement of IgG to SARS-CoV-2 antigens using monoclonal antibody-based enzyme-linked immunosorbent assays
Neutralizing antibody titres in SARS-CoV-2 infections
The early antibody response to SARS-Cov-2 infection
Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
Monoclonal antibody therapy
In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
Casirivimab-imdevimab monoclonal antibody treatment for an immunocompromised patient with persistent SARS-CoV-2 infection: a case report
Quantitative measurement of IgG to SARS-CoV-2 antigens using monoclonal antibody-based enzyme-linked immunosorbent assays
Neutralizing antibody titres in SARS-CoV-2 infections
The early antibody response to SARS-Cov-2 infection
Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
Monoclonal antibody therapy
In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
Casirivimab-imdevimab monoclonal antibody treatment for an immunocompromised patient with persistent SARS-CoV-2 infection: a case report
Quantitative measurement of IgG to SARS-CoV-2 antigens using monoclonal antibody-based enzyme-linked immunosorbent assays
Neutralizing antibody titres in SARS-CoV-2 infections
The early antibody response to SARS-Cov-2 infection